Register of
Medicinal Products

Product class: Authorized package
Medicinal product class: For human use
Package code: 1843084
Name of medicinal product: BIMATOPROST/TIMOLOL ELVIM
Active substances:
Timolol+Bimatoprost
Estonian, English, Latin
ATC code: S01ED82
Dosage form: eye drops, solution
Route of administration: ocular use
Strengh: 5mg+0,3mg 1ml
Amount in package: 3ml 1TK
Legal status for supply*: Subject to medicinal prescription
Class of active substance:  
Additional information:  
Indication: Reduction of intraocular pressure (IOP) in adult patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.
Safety features: Yes
Summary of product characteristics (SPC):  (last updated April 5, 2022)
Package information leaflet (PIL): EST  (last updated April 5, 2022)
Labelling:  (last updated April 5, 2022)
Last imported to Estonia: March 28, 2023
Marketing authorization holder: Elvim SIA 
Marketing authorization number: 1058122 
Marketing authorization issued on: April 5, 2022 
Marketing authorization expires on: April 5, 2027 
Marketing authorization procedure type: Decentralised 
Percent Valid from Valid until Valid Diagnosis Doctor's speciality Primary Age Other
50  01.04.2023     Yes      No      
100  01.04.2023     Yes  H40-H42  Oftalmoloog  Yes      
100  01.04.2023     Yes      No  until 4 years   
100  01.04.2023     Yes  H40-H42  Oftalmoloog  Yes  until 4 years   
Reference price: 7,50 EUR 
Under reference price: Yes 
Reference price of daily dose: 0,25 EUR 
Entry/Changing date: April 5, 2022
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription

You can download Acrobat Reader fromhere